Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery

Colloids and Surfaces B: Biointerfaces

Volumn 16, Issue 1-4, 1999, Pages 93-111

  Rapoport, Natalya ^a  

^a Department of Electrical and Computer Engineering   (United States)

Author keywords

Doxorubicin; Drug delivery; Electron paramagnetic resonance; Fluorescence spectroscopy; Micelle stabilization; Micellization; Pluronic; Polymeric micelles; Ruboxyl; Ultrasound

Indexed keywords

DOXORUBICIN; POLOXAMER; RUBOXYL;

ARTICLE; CANCER CHEMOTHERAPY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TARGETING; ELECTRON SPIN RESONANCE; MICELLE; MOLECULAR STABILITY; PHASE TRANSITION; POLYMERIZATION; PRIORITY JOURNAL;

EID: 0032828457     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0927-7765(99)00063-6     Document Type: Article

References (41)

1. Jeon S.I., Lee J.H., Andrade J.D., Gennes P.G.D. J. Colloid Interface Sci. 142:1991;149-158.
2. Kataoka K., Kwon G.S., Yokoyama M., Okano T., Sakurai Y. J. Controlled Release. 24:1993;119-132.
3. Li J.-T., Caldwell K.D., Rapoport N. Langmuir. 10:1994;4475-4482.
4. Cammas S., Kataoka K. Webber S.E. Solvents and Self-Organization of Polymers. 1996;83-113 Kluwer Academic, The Netherlands.
5. Yokoyama M. Okano T. Advances in Polymeric Systems for Drug Delivery. 1994;24-66 Gordon and Breach Science Publishers, Iverdon, Switzerland.
6. M. Yokoyama, Polymeric micelles for drug delivery: their strategy and perspectives., 17th International Symposium on Recent Advantages in Drug Delivery Systems, 1995, pp. 99-102.
7. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K. Cancer Res. 51:1991;3229-3236.
8. Kwon G.S., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Pharmac. Res. 10:1993;970-974.
9. Kwon G., Naito M., Yokoyama M., Sakurai Y., Okano T., Kataoka K. Langmuir. 9:1993;945-949.
10. G.S. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, K. Kataoka, Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-co-aspartate) block copolymer-Adriamycin conjugates, 6th International Symposium on Recent Advantages in Drug Delivery Systems, 1993, pp. 175-176.
11. Kwon G.S., Kataoka K. Adv. Drug Deliv. Rev. 16:1995;295-309.
12. Kwon G.S., Suwa S., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Pharm. Res. 12:1995;192-195.
13. Kwon G.S., Naito M., Kataoka K., Yokoyama M., Sakurai Y., Okano T. Colloids Surf. B: Biointerfaces. 2:1994;429-434.
14. Kabanov A.V., Batrakova E.V., Melik-Nubarov N.S., Fedoseev N.A., Dorodnich T.Y., Alakhov V.Y., Nazarova I.R., Kabanov V.A. J. Controlled Release. 22:1992;141-158.
15. Kabanov A.V., Nazarova I.R., Astafieva I.V., Batrakova E.V., Alakhov V.Y., Yaroslavov A.A., Kabanov V.A. Macromolecules. 28:1995;2303-2314.
16. Rapoport N., Caldwell K. Colloids Surf. B: Biointerfaces. 3:1994;217-228.
17. Alakhov V.Yu., Kabanov A.V. Expert Op. Invest. Drugs. 7:1998;1453-1473.
18. Batrakova E.V., Dorodnych T.Y., Klinskii E.Y., Kliushnenkova E.N., Shemchukova O.B., Goncharova O.N., Arjakov S.A., Alakhov V.Y., Kabanov A.V. Br. J. Cancer. 74:1996;1545-1552.
19. V.Y. Alakhov, E.V. Batrakova, T. Dorodnich, S. Li, A. Venne, A.V. Kabanov, Block copolymeric drug carriers: 1, delivery of antineoplastic drugs., First International Symposium on Polymer Therapeutics, The School of Pharmacy, University of London, UK, London, 1996, p. 213.
20. Alakhov V., Moskaleva E., Batrakova E., Kabanov A. Bioconjug. Chem. 7:1996;209-216.
21. N. Rapoport, in: 11th International Symposium on Surfactants In Solution, Jerusalem, Israel, 1996, p. 183.
22. Alexandridis P., Hatton T.A. Colloids Surf. A: Physicochem. Eng. Asp. 96:1995;1-46.
23. Rolland A., O'Mullane J., Goddard P., Brookman L., Petrak K. J. Appl. Polym. Sci. 44:1992;1195-1203.
24. Dorn K., Hoerpel G., Ringsdorf H. Gebelein C.G., Carraher J.C.E. Bioactive Polymer Systems. 1985;531-585 Plenum, New York.
25. Yokoyama M., Kwon G.S., Naito M., Okano T., sakurai Y., Seto T., Kataoka K. Bioconj. Chem. 3:1992;295-301.
26. Yokoyama M., Sugiyama T., Okano T., Sakurai Y., Naito M., Kataoka K. Pharmac. Res. 10:1993;895-899.
27. M. Yokoyama, G. S. Kwon, T. Okano, Y. Sakurai, H. Ekimoto, K. Kataoka, In vivo antitumor activity of polymeric micelle-anticancer drug conjugates against murine C 26 tumor, 6th International Symposium on Recent Advantages in Drug Delivery Systems, 1993, pp. 177-178.
28. Alakhov V.Y., Moskaleva E.Y., Batrakova E.V., Kabanov A.V. Bioconj. Chem. 7:1996;209-216.
29. Venne A., Li S., Mandeville R., Kabanov A., Alakhov V. Cancer Res. 56:1996;3626-3629.
30. Rapoport N., Munshi N., Pitina L., Pitt W.G. Polym. Prepr. 38:1997;620-621.
31. Rapoport N., Herron J.N., Pitt W.G., Pitina L. J. Controlled Release. 58:1999;153-162.
32. Munshi N., Rapoport N., Pitt W.G. Cancer Lett. 117:1997;1-7.
33. Miller D., Batrakova E., Waltner T., Alakhov V., Kabanov A. Bioconjug. Chem. 8:1997;649-657.
34. Rapoport N., Smirnov A., Timoshin A., Pratt A.M., Pitt W.G. Arch. Biochem. Biophys. 344:1997;114-124.
35. Smirnov A.I., Belford R.L. Arch. Biochem. Biophys. 362:1999;233-241.
36. Zhou Z., Chu B. J. Colloid Interface Sci. 126:1988;171-180.
37. Brown W., Schillen K., Almgren M., Hvidt S., Bahadur P. J. Phys. Chem. 95:1991;1850.
38. W.B. Pratt, R.W. Ruddon, W.D. Ensminger. J. Maybaum, Noncovalent DNA-Binding Drugs, The Anticancer Drugs, Oxford University Press, New York, Oxford, 1994, pp. 155-182.
39. Emanuel N.M., Bogdanov G.N., Orlov V.S. Russ. Chem. Rev. 53:1984;1121-1138.
40. N.M. Emanuel, N.P. Konovalova, L.S. Povarov, A.B. Shapiro, et al. Russian Academy of Sciences, 13-(1-oxyl-2,2,6,6-tetramethylpiperylidenyl-4)hydrozone rubomycin hydrochloride with a paramagnetic center and a method of producing same (1982).
41. Bednarski M.D., Lee J.W., Callstrom M.R., Li K.C. Radiology. 204:1997;263-268.